Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer

A Phase 1 Dose Escalation and Expansion Study Of SHR7280 In Subjects With Hormone Sensitive Prostate Cancer

NCT04995042 ·Status: COMPLETED ·Phase: PHASE1

Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study

NCT07163910 ·Status: RECRUITING ·Phase: PHASE2

Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer

NCT05707468 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC

NCT05670106 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer

NCT06834321 ·Status: RECRUITING ·Phase: PHASE2

Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer

NCT04220398 ·Status: UNKNOWN ·Phase: NA

Cilengitide in Treating Patients With Prostate Cancer

NCT00121238 ·Status: COMPLETED ·Phase: PHASE2

A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients

NCT02691975 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer

NCT00058539 ·Status: COMPLETED ·Phase: PHASE2

A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer

NCT07230106 ·Status: RECRUITING ·Phase: PHASE2

Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy

NCT00148772 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Bone Mineral Loss in Prostate Cancer Patients Who is Receiving GnRH Agonist and -Plus Anti-androgen Agent

NCT01303692 ·Status: COMPLETED

Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.

NCT01123434 ·Status: COMPLETED

Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations

NCT05457257 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Evaluating the Safety and Efficacy of 177Lu-LNC1011 Injection in a Single-Center, Single-Arm, Open Study in Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Desmoplasia-Resistant Prostate Cancer

NCT06809426 ·Status: COMPLETED ·Phase: NA

Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)

NCT06387056 ·Status: RECRUITING ·Phase: PHASE2

Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer

NCT01734681 ·Status: WITHDRAWN ·Phase: PHASE2

Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer

NCT06006104 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer

NCT01511874 ·Status: COMPLETED ·Phase: PHASE4

S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy

NCT01309672 ·Status: COMPLETED ·Phase: PHASE2

Development of a Novel Signature Integrating Clinical, Imaging And Epigenetic Information to Tailor Pelvic Nodal Treatment in Prostate Cancer

NCT06807398 ·Status: COMPLETED

CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer

NCT00075192 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

NCT00118092 ·Status: COMPLETED ·Phase: PHASE2

COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer

NCT03241537 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients

NCT00166725 ·Status: COMPLETED ·Phase: PHASE2